bendazac has been researched along with Anemia, Aplastic in 1 studies
bendazac : A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alcalde, M | 1 |
García-Díaz, M | 1 |
Najarro, F | 1 |
Pascasio, JM | 1 |
1 other study available for bendazac and Anemia, Aplastic
Article | Year |
---|---|
[Toxic and autoimmune type I-like hepatitis and hyporegenerative anemia caused by bendazac].
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Disea | 1994 |